Abstract
Purpose
Brazil has one of the world’s highest numbers of patients on hemodialysis (HD). Most dialysis centers are private and perform HD for patients with private and public health insurance. We compared 1-year survival between patients initiating chronic HD with public and private health insurance.
Methods
This is an HD register-based retrospective cohort. Adult patients starting HD from January 2011 to December 2021 were included. Survival analysis was stratified according to the period entered in the HD register. Multivariate Cox regression focused on 1-year survival differences between private and public patients.
Results
In the final sample (n = 5114), 68.5% of participants had public and 31.3% to private health insurance, with overall 1-year survival of 92.8% and 89.9%, respectively (p = 0.002). Crude analysis showed a slightly higher survival rate among patients with public health insurance than those with private health insurance (91 vs. 87%, p = 0.030) in the first period (2019–21). However, the adjusted hazard ratio (HR) did not remain significantly higher for patients with private health insurance compared to those with public health insurance (HR = 1.07; 95% CI 0.80–1.41; p = 0.651), even after propensity score matching of the groups by several baseline features.
Conclusion
Brazilian chronic HD patients funded by either private health plans or the public system have a similar 1-year mortality risk after controlling for several sociodemographic and clinical parameters.
Similar content being viewed by others
References
Thurlow JS, Joshi M, Yan G, Norris KC, Agodoa LY, Yuan CM et al (2021) Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol 52(2):98–107
Nerbass FB, Lima HdN, Thomé FS, Neto OMV, Lugon JR, Sesso R (2023) Brazilian dialysis survey 2021. J Bras Nefrol 45(2):192–198
Neves P, Sesso RCC, Thome FS, Lugon JR, Nascimento MM (2021) Brazilian dialysis survey 2019. J Bras Nefrol 43(2):217–227
Vieira FS (2020) Health financing in Brazil and the goals of the 2030 agenda: high risk of failure. Rev Saude Publica 54(127):1-12.5
Castro MC, Massuda A, Almeida G, Menezes-Filho NA, Andrade MV, de Souza Noronha KVM et al (2019) Brazil’s unified health system: the first 30 years and prospects for the future. Lancet 394(10195):345–356
Barros MBdA, César CLG, Carandina L, Torre GD (2006) Social inequalities in the prevalence of chronic diseases in Brazil, PNAD-2003. Cien Saude Colet 11(4):911–926
Sesso R, Lugon JR (2020) Global dialysis perspective: Brazil. Kidney360. https://doi.org/10.34067/KID.0000642019
Loesch G, Cruz JAW, Pecoits-Filho R, Figueiredo AE, Barretti P, de Moraes TP (2020) Public health investments and mortality risk in Brazilian peritoneal dialysis patients. Clin Kidney J 13(6):1012–1016
Szuster DAC, Caiaffa WT, Andrade EIG, Acurcio FdA, Cherchiglia ML (2012) Survival analysis of dialysis patients in the Brazilian unified national health system. Cad Saúde Pública 28(3):415–424
Matos JP, Almeida JR, Guinsburg A, Marelli C, Barra AB, Vasconcellos MS et al (2011) Assessment of a five-year survival on hemodialysis in Brazil: a cohort of 3082 incident patients. J Bras Nefrol 33(4):436–441
Barra ABL, Roque-da-Silva AP, Canziani MEF, Lugon JR, Strogoff-de-Matos JP (2022) Characteristics and predictors of mortality on hemodialysis in Brazil: a cohort of 5081 incident patients. BMC Nephrol 23(1):77
Szwarcwald CL, Souza Junior PR, Marques AP, Almeida WD, Montilla DE (2016) Inequalities in healthy life expectancy by Brazilian geographic regions: findings from the national health survey, 2013. Int J Equity Health 15(1):141
Neves P, Sesso RCC, Thome FS, Lugon JR, Nascimento MM (2020) Brazilian dialysis census: analysis of data from the 2009–2018 decade. J Bras Nefrol 42(2):191–200
LaMd S, Mezzomo NF, Pansard HM, Lc A, Rempel W, Argenta LC et al (2009) Survival in chronic hemodialysis: study of a cohort of 1009 patients in 25 years. Braz J Nephrol 31(2):190–197
Luxardo R, Ceretta L, Gonzalez-Bedat M, Ferreiro A, Rosa-Diez G (2022) The Latin American dialysis and renal transplantation registry: report 2019. Clin Kidney J 15(3):425–431
Kirkwood BR (2003) Sterne JAC (2003) Strategies for analysis. In: Kirkwood BR, Sterne JAC (eds) Essential Medical Statistics. Blackwell Science, Oxford, pp 458–469
Bello AK, Okpechi IG, Osman MA, Cho Y, Htay H, Jha V et al (2022) Epidemiology of haemodialysis outcomes. Nat Rev Nephrol 18:378–395
Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE et al (2003) Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the dialysis outcomes and practice patterns study (DOPPS). J Am Soc Nephrol 14(12):3270–3277
Lima HN, Nerbass FB, Lugon JR, Sesso R (2023) Characteristics and 1-year survival of incidental patients on chronic peritoneal dialysis compared with hemodialysis: a large 11-year cohort study. Int Urol Nephrol 55(8):2025–2033
Botega LA, Andrade MV, Guedes GR (2020) Brazilian hospitals’ performance: an accessment of unified health system (SUS). Health Care Manag Sci 23(3):443–452
Lima LDd, Albuquerque MVd, JoHG S, Melo ECPd, Oliveira EXGd, Carvalho MS et al (2019) Regional governance arrangements of the Brazilian unified national health system: provider diversity and spacial inequality in service provision. Cad Saúde Pública. https://doi.org/10.1590/0102-311x00094618
Vincens N, Stafstrom M (2015) Income inequality, economic growth and stroke mortality in Brazil: longitudinal and regional analysis 2002–2009. PLoS ONE 10(9):e0137332
Nerbass FB, Lima HN, Moura-Neto JA, Lugon JR, Sesso R (2023) Brazilian dialysis survey 2022. Braz J Nephrol. https://doi.org/10.1590/2175-8239-JBN-2023-0062en
Liu FX, Rutherford P, Smoyer-Tomic K, Prichard S, Laplante S (2015) A global overview of renal registries: a systematic review. BMC Nephrol 16:31
Acknowledgements
We want to thank all the support received by the Brazilian Society of Nephrology and from the Researchers of the Brazilian Registry of Dialysis mentioned below: Roberto Benvenutti; Márcio A. Moraes; Natasha S. Constancio; Ian R. Rehfeldt; Fabia Fernandez; Rodrigo Braz; Neyde V. Pontes; Gelzie S. Ennes; Marcos A. Mura; Rosilene Coelho; Jair B. Miguel; Márcia B. Hexsel Abichequer; Silvia C. Medeiros; Gelson A. dos Santos; João C. Biernat; Orlando B. Junior; Eli N. da Silva; Nilsa R. Martins; Patrícia S. Teixeira; Luciana F. Serpa; Cristina L. Pinto; Antonio A. C. de Brito; Luiz C. A.Gonçalves; Rosa Malta; Sinaria A. Ojeda; Jorge A.V. de Menezes; Maria P. de Souza; Tania D.Sobral; Ismar C. M. Junior; Cristiano V. da Silva; Gisele F. Furtado; Silvana M. Oliveira; Luiz F. B. de Figueiredo; Maria E. D. Diniz; Sérgio G.E. Bucharles; João D. S. Simões; Geraldo A. Córdova; Renata L. Starling; Sandra T. S.N. Coelho; Mendell D.Lemos; Maria F. Alvarenga; Ana L.Cabeça; Beatriz Veneza; José M. V. Obregón; Fernanda S. G. Polacchini; Hotone Dallacosta; Marcelo F. Ruas; Yoshimi Watanabe; André L. Marassi; Leandro J. Lucca; Cyro N. F. M. Filho; Wagner S. Catharina; Fernando S. Thomé; Milene C.D. Guilhem; Jeronimo R. Centeno; Flavio M. de Paula; Marcos Gevert; Marco Túlio; Renato J. P. de Medeiros; Manif C, Jorge; Nelson José; Consuelo V. de Carvalho; Ana B. B. Palazzo; Carlos E. Comin; Marcelo A. Gonçalves; Maziael Moraes; Henrique L. Carrascossi; Januário G. Roberto; Roberto E. Salon; Marilia B. Oliveira; Flávio J. D. de Moura; Helio E. Galvão; Ana C. V. do Amaral Barbosa; Zita M. Leme; Raimundo M. Neto; Mario E. Rodrigues; Elzo R. Junior; Maria G. Polito; Tânia Brandão; Angela Barros; Glória M. F. dos Reis; João C. Filho; Aparecida P.G. Visoná; Nilso Moreira; Rodrigo M. Pereira; Ricardo A. Mothé; Homero N. C e .A. Sul; Fernando F. Neto; Jadny J. Dornelas; Ciro T. Costa; Jorge L. Z. Ramos.
Funding
This study has been done without funding or support grants, just with support funding for publication by the Brazilian Society of Nephrology. RS receives a research grant from the Brazilian Research Council (CNPq).
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest about the study performed.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The complete details of author involved in the Brazilian Dialysis Register Investigators are given in Acknowledgements.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
do Nascimento Lima, H., Monárrez-Espino, J., Nerbass, F.B. et al. Comparison of 1-year survival between patients initiating chronic hemodialysis under public and private health insurance: register-based data analysis from Brazil. Int Urol Nephrol (2024). https://doi.org/10.1007/s11255-024-04018-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11255-024-04018-4